|
|
Volumn 11, Issue 4, 2002, Pages 231-237
|
|
The A-B neuropsychological assessment schedule (ABNAS): The relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests
|
|
Author keywords
Antiepileptics; Cognitive effects; Cognitive side effects; Mood effects
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
BENZODIAZEPINE;
CARBAMAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
TOPIRAMATE;
ADULT;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
COMPUTER SYSTEM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISCRIMINANT ANALYSIS;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INDUCED DISEASE;
EPILEPSY;
FEMALE;
FINANCIAL MANAGEMENT;
FINGER;
HIGH RISK PATIENT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MOTOR SYSTEM;
NEUROPSYCHOLOGICAL TEST;
PATIENT REFERRAL;
PATIENT SELECTION;
PERCEPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
REACTION TIME;
RELIABILITY;
RESPONSE TIME;
RISK ASSESSMENT;
SCORING SYSTEM;
SCREENING TEST;
SENSITIVITY ANALYSIS;
TASK PERFORMANCE;
TIME;
TITRIMETRY;
VALIDATION PROCESS;
VERBAL MEMORY;
VISION TEST;
|
|
EID: 0036306499
PISSN: 10591311
EISSN: None
Source Type: Journal
DOI: 10.1053/seiz.2002.0672 Document Type: Article |
|
Times cited : (32)
|
|
References (20)
|
